Published in Eur J Immunol on April 01, 1990
Positive and negative transcriptional regulation of the Escherichia coli gluconate regulon gene gntT by GntR and the cyclic AMP (cAMP)-cAMP receptor protein complex. J Bacteriol (1998) 1.35
Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. J Exp Med (1994) 1.22
Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection. PLoS Pathog (2008) 1.19
Characterization and immunolocalization of a Cryptosporidium protein containing repeated amino acid motifs. Infect Immun (1993) 1.15
High-level expression, refolding and probing the natural fold of the human voltage-dependent anion channel isoforms I and II. J Membr Biol (2007) 1.06
Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine. Clin Exp Immunol (1999) 0.95
Multiple antigen peptide vaccines against Plasmodium falciparum malaria. Infect Immun (2010) 0.93
Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein. Infect Immun (1993) 0.89
Circumsporozoite protein as a potential target for antimalarials. Expert Rev Anti Infect Ther (2015) 0.75
Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A (1984) 7.77
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci U S A (1988) 6.74
A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature (1989) 3.33
Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl Acad Sci U S A (1991) 3.15
Compensatory mutations suggest that base-pairing with a small nuclear RNA is required to form the 3' end of H3 messenger RNA. Nature (1986) 2.74
Structural studies of immunoglobulin G. Nature (1969) 2.63
Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation. EMBO J (1986) 2.41
Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature (1995) 2.30
Immunohistochemical detection of prion protein in lymphoid tissues of sheep with natural scrapie. J Clin Microbiol (1996) 2.26
Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein. Proc Natl Acad Sci U S A (1985) 2.23
Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell (1989) 2.20
Human immunoglobulin subclasses. Partial amino acid sequence of the constant region of a gamma 4 chain. Biochem J (1970) 2.11
Subregions of a conserved part of the HIV gp41 transmembrane protein are differentially recognized by antibodies of infected individuals. EMBO J (1986) 2.01
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 2.00
Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature (1992) 1.98
Structure and evolution of immunoglobulins. Prog Biophys Mol Biol (1970) 1.96
An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem Pharmacol (1998) 1.90
Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J Immunol (1987) 1.89
Activation of p70s6k is associated with phosphorylation of four clustered sites displaying Ser/Thr-Pro motifs. Proc Natl Acad Sci U S A (1992) 1.79
Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition. AIDS (1988) 1.68
The T-cell-receptor repertoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal. Proc Natl Acad Sci U S A (1991) 1.67
4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother (1996) 1.65
Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect Immun (1991) 1.60
A naturally occurring gene encoding the major surface antigen precursor p190 of Plasmodium falciparum lacks tripeptide repeats. EMBO J (1987) 1.58
A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins. J Gen Virol (1980) 1.57
Immunohistochemical detection and localization of prion protein in brain tissue of sheep with natural scrapie. Vet Pathol (1995) 1.52
Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia (2012) 1.51
Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein. Virology (1991) 1.51
Localisation of Nramp1 in macrophages: modulation with activation and infection. J Cell Sci (1998) 1.50
Selection of T cell epitopes and vaccine engineering. Methods Enzymol (1991) 1.50
Use of prior vaccinations for the development of new vaccines. Science (1990) 1.48
Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1. Arch Virol (1992) 1.37
The gene encoding the T-cell receptor alpha-chain maps close to the Np-2 locus on mouse chromosome 14. Nature (1985) 1.37
A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur J Immunol (1990) 1.35
Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3. Mol Biochem Parasitol (1997) 1.34
Nonpolymorphic regions of p190, a protein of the Plasmodium falciparum erythrocytic stage, contain both T and B cell epitopes. J Immunol (1988) 1.31
Rearrangement of chicken immunoglobulin genes is not an ongoing process in the embryonic bursa of Fabricius. Proc Natl Acad Sci U S A (1986) 1.29
Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum. J Immunol (1988) 1.28
Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J Immunol (1992) 1.27
Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol (1997) 1.27
In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants. Eur J Immunol (1993) 1.24
A common mechanism for blockade of heme polymerization by antimalarial quinolines. J Biol Chem (1998) 1.23
Catalytic domains of the LAR and CD45 protein tyrosine phosphatases from Escherichia coli expression systems: purification and characterization for specificity and mechanism. Biochemistry (1992) 1.23
B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface. J Virol (1993) 1.23
Characterisation and sequence of a protective rhoptry antigen from Plasmodium falciparum. Mol Biochem Parasitol (1990) 1.22
Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses. J Gen Virol (1979) 1.22
Distribution, prevalence, and drug binding profile of gamma-aminobutyric acid type A receptor subtypes differing in the beta-subunit variant. J Biol Chem (1994) 1.22
The circumsporozoite protein gene from NF54, a Plasmodium falciparum isolate used in malaria vaccine trials. Mol Biochem Parasitol (1989) 1.20
Structural aspects of antibody-antigen interaction revealed through small random peptide libraries. Mol Divers (1996) 1.20
Inter heavy-light chain disulphide bridge in immune globulins. Nature (1967) 1.20
Efficient mapping and characterization of a T cell epitope by the simultaneous synthesis of multiple peptides. Eur J Immunol (1989) 1.20
Epitopes recognized by human T cells map within the conserved part of the GP190 of P. falciparum. Science (1988) 1.19
Expression and characterisation of plasmepsin I from Plasmodium falciparum. Eur J Biochem (1997) 1.19
A variable region subclass of heavy chains common to immunoglobulins G, A, and M and characterized by an unblocked amino-terminal residue. Proc Natl Acad Sci U S A (1970) 1.19
A comparison and analysis of several ways to promote haematin (haem) polymerisation and an assessment of its initiation in vitro. Biochem Pharmacol (1998) 1.19
First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J Virol (1994) 1.17
Major surface antigen p190 of Plasmodium falciparum: detection of common epitopes present in a variety of plasmodia isolates. EMBO J (1988) 1.17
Aldolase activity of a Plasmodium falciparum protein with protective properties. Science (1988) 1.17
Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligopeptides. J Virol Methods (1988) 1.17
A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. J Virol (1993) 1.16
Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol (1997) 1.16
T-lymphocyte differentiation is accompanied by increase in sialic acid content of Thy-1 antigen. Nature (1980) 1.16
HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate. Int Immunol (1991) 1.16
Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus. J Gen Virol (1996) 1.15
Dynamics and binding mode of Hoechst 33258 to d(GTGGAATTCCAC)2 in the 1:1 solution complex as determined by two-dimensional 1H NMR. Biochemistry (1991) 1.15
[New aspects of the part of the vector played by Ixodes ricinus L. in Switzerland. Preliminary note (author's transl)]. Acta Trop (1979) 1.15
Plasmodium falciparum-specific human T cell clones: evidence for helper and cytotoxic activities. Eur J Immunol (1987) 1.14
Diversity of antibodies to cross-reacting nitrophenyl haptens in inbred mice. Eur J Immunol (1974) 1.12
European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides, and reactivity with monoclonal antibodies. Arch Virol (1985) 1.10
Purification and characterization of a soluble catalytic fragment of the human transmembrane leukocyte antigen related (LAR) protein tyrosine phosphatase from an Escherichia coli expression system. Biochemistry (1991) 1.10
Variability of interchain binding of immunoglobulins. Interchain bridges of mouse IgG2a and IgG2b. Nature (1970) 1.09
Counting components of the chicken's B cell system. Immunol Rev (1986) 1.09
Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein. Eur J Immunol (1988) 1.09
Nomenclature for chicken major histocompatibility (B) complex. Immunogenetics (1982) 1.08
Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus. J Virol (1997) 1.08
Map of sequential B cell epitopes of the HIV-1 transmembrane protein using human antibodies as probe. Intervirology (1990) 1.07
Hematin polymerization assay as a high-throughput screen for identification of new antimalarial pharmacophores. Antimicrob Agents Chemother (2000) 1.07
Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. J Gen Virol (1989) 1.06
Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus. J Gen Virol (1987) 1.06
Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth. J Med Chem (1999) 1.05
Studies of an unusual biclonal gammopathy: implications with regard to genetic control of normal immunoglobulin synthesis. Ann N Y Acad Sci (1971) 1.05
Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G. J Immunol Methods (1996) 1.04
Association of degradation and secretion of three chimeric polypeptides in Escherichia coli. J Bacteriol (1988) 1.03
Biology of the chicken MHC (B complex). Crit Rev Immunol (1992) 1.03
An enzyme-linked immunosorbent assay (ELISA) for the detection of antibody against Aujeszky's disease virus in pig sera. Zentralbl Veterinarmed B (1979) 1.03
A new attempt to distinguish serologically the subspecies of Treponema pallidum causing syphilis and yaws. J Clin Microbiol (1990) 1.03
Neutralizing activity of anti-peptide antibodies against the principal neutralization domain of human immunodeficiency virus type 1. J Gen Virol (1991) 1.02
Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies. Virology (1998) 1.02
Identical genes for trimethoprim-resistant dihydrofolate reductase from Staphylococcus aureus in Australia and central Europe. FEBS Lett (1990) 1.02
Isolation and characterization of trypsin-resistant O1 variants of foot-and-mouth disease virus. J Gen Virol (1979) 1.02
Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine. J Gen Virol (1991) 1.00
Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J Virol (1995) 1.00
T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2. J Immunol (1993) 1.00
Avian B cell precursors: surface immunoglobulin expression is an early, possibly bursa-independent event. Eur J Immunol (1986) 0.99
C-reactive protein protects against preerythrocytic stages of malaria. Infect Immun (1989) 0.99